PD40-12 DEFINING THE IMPACT OF PERIOPERATIVE MORBIDITY FROM CYTOREDUCTIVE NEPHRECTOMY ON THE TIMING OF SYSTEMIC THERAPY: A CONTEMPORARY SERIES FROM FIVE CENTERS

INTRODUCTION AND OBJECTIVE:For metastatic renal cell cancer (mRCC) patients considering cytoreductive nephrectomy (CN), perioperative morbidity may delay or preclude post-operative systemic therapy...